肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1232-1235.

• 肝纤维化及肝硬化 • 上一篇    下一篇

肝脾硬度联合测定无创评估慢性乙型肝炎纤维化分期的临床价值

王义茹, 丁蕾, 孟繁坤   

  1. 100069 北京 首都医科大学附属北京佑安医院超声诊断中心
  • 收稿日期:2025-11-04 出版日期:2026-09-30 发布日期:2026-11-16
  • 通讯作者: 孟繁坤,Email: mengfankun818@126.com

The clinical application value of combined measurement of liver and spleen stiffness in non-invasive assessment of fibrosis stages in chronic hepatitis B

Wang Yiru, Ding Lei, Meng Fankun   

  1. Ultrasound Diagnosis Center,Beijing You'an Hospital,Capital Medical University,Beijing 100069,China
  • Received:2025-11-04 Online:2026-09-30 Published:2026-11-16
  • Contact: Meng Fankun, Email: mengfankun818@126.com

摘要: 目的 探讨肝脾硬度联合测定无创评估慢性乙型肝炎(CHB)纤维化分期的临床应用价值。方法 纳入首都医科大学附属北京佑安医院123例行肝组织活检的CHB患者。检测脾脏硬度(SSM)、肝脏硬度(LSM),以病理结果为金标准,分析LSM联合SSM对CHB肝纤维化分期的诊断价值。结果 在123例CHB患者中,S0~S4期患者例数分别为18例、58例、16例、16例、15例,对应的LSM分别为4.30(3.52,6.00)、4.65(3.80,5.92)、7.50(5.02,7.97)、10.85(9.07,13.15)、13.20(11.50,17.80)kPa;SSM分别为14.55(13.42,16.17)、14.30(12.10,18.22)、21.15(16.82,23.95)、22.85(18.82,27.05)、30.50(23.40,40.00)kPa,LSM、SSM值均随着肝纤维化进展而增加,差异有统计学意义(P<0.001)。LSM及SSM与肝纤维化分期均呈正相关(r=0.709、0.655,P均<0.001),将其分为显著纤维化组(≥S2期)与非显著纤维化组(≤S1期)。应用LSM及SSM诊断显著肝纤维化(≥S2期)最佳诊断截断值分别为7.45、20.65 kPa;ROC曲线下面积分别为0.919、0.909;LSM与SSM诊断显著肝纤维化(≥S2期)的诊断效能相当,差异无统计学意义(Z=0.314,P=0.075)。LSM联合SSM诊断显著肝纤维化(≥S2期)的ROC曲线下面积为0.948;与单独使用LSM或SSM相比,诊断效能显著提高,差异有统计学意义(Z=1.968、2.018,P=0.0491、0.0436)。结论 瞬时弹性成像技术测得LSM及SSM对于显著肝纤维化(≥S2期)的诊断效能相当,两者联合后可提高诊断效能。

关键词: 慢性乙型肝炎, 瞬时弹性成像技术, 肝硬度, 脾硬度, 肝纤维化

Abstract: Objective To explore the clinical application value of combined measurement of liver and spleen stiffness in the non-invasive assessment of liver fibrosis stages in chronic hepatitis B (CHB) patients. Methods A total of 123 CHB patients who underwent liver biopsy were enrolled in Beijing You'an Hospital, Capital Medical University. The spleen stiffness (SSM) and liver stiffness (LSM) of all patients were measured. With pathological results as the gold standard, the diagnostic value of combined liver and spleen stiffness for hepatitis B-related liver fibrosis staging was analyzed. Results Among 123 patients with hepatitis B, the number of patients at stages S0 to S4 was 18, 58, 16, 16, and 15 respectively. The LSM values were 4.30 (3.52, 6.00), 4.65 (3.80, 5.92), 7.50 (5.02, 7.97), 10.85 (9.07, 13.15), and 13.20 (11.50, 17.80) kPa, and the SSM values were 14.55 (13.42, 16.17), 14.30 (12.10, 18.22), 21.15 (16.82, 23.95), 22.85 (18.82, 27.05), and 30.50 (23.40, 40.00) kPa, respectively. Both LSM and SSM values increased with the progression of liver fibrosis, and the difference was statistically significant (P<0.001). LSM and SSM were both positively correlated with liver fibrosis stages (r=0.709 and 0.655, respectively; both P<0.001). The patients were divided into a significant fibrosis group (≥ stage S2) and a non-significant fibrosis group (≤stage S1). The optimal diagnostic cut-off values of LSM and SSM for diagnosing significant liver fibrosis (≥ stage S2) were 7.45 kPa and 20.65 kPa, respectively, with the areas under the receiver operating characteristic curve (AUC) being 0.919 and 0.909. The diagnostic efficacy of LSM for significant liver fibrosis (≥stage S2) was comparable to that of SSM, and the difference was not statistically significant (Z=0.314, P=0.075). The AUC of the combined use of LSM and SSM for diagnosing significant liver fibrosis (≥ stage S2) was 0.948. Compared with the single usage of LSM or SSM, the diagnostic efficacy was significantly improved, and the differences were statistically significant (Z=1.968 and 2.018, P=0.0491 and 0.0436, respectively). Conclusion The diagnostic efficacy of LSM and SSM measured by transient elastography for significant liver fibrosis (≥ stage S2) is comparable, and their combination can improve the diagnostic efficacy.

Key words: Chronic hepatitis B, Transient elastography, Spleen stiffness, Liver stiffness, Liver fibrosis